Order Article Reprints

Vo HH, Cartwright C, Song I-W, Karp DD, Nogueras Gonzalez GM, Xie Y, Karol M, Hitron M, Vining D, Tsimberidou A-M. Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center. Cancers. 2022; 14(5):1330. https://doi.org/10.3390/cancers14051330

Vo, Henry Hiep, Carrie Cartwright, I-Wen Song, Daniel D. Karp, Graciela M. Nogueras Gonzalez, Yuran Xie, Michael Karol, Matthew Hitron, David Vining, and Apostolia-Maria Tsimberidou. 2022. "Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center" Cancers 14, no. 5: 1330. https://doi.org/10.3390/cancers14051330

Vo, H. H., Cartwright, C., Song, I.-W., Karp, D. D., Nogueras Gonzalez, G. M., Xie, Y., Karol, M., Hitron, M., Vining, D., & Tsimberidou, A.-M. (2022). Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center. Cancers, 14(5), 1330. https://doi.org/10.3390/cancers14051330